Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Halvard Bonig

Showing results (131-140 of 146) with videos related to

Pageof 15
Sort By:
Bone Marrow Transplantation|December 25, 2021
Results of a multicenter phase I/II trial of TCRαβ and CD19-depleted haploidentical hematopoietic stem cell transplantation for adult and pediatric patientsWolfgang A Bethge, Matthias Eyrich, Stephan Mielke, et al.
Journal of Translational Medicine|June 13, 2024
Correction: Real‑world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC‑FFM in ruxolitinib‑refractory acute graft‑versus‑host diseaseHalvard Bonig, Mareike Verbeek, Peter Herhaus, et al.
Journal of Translational Medicine|November 22, 2023
Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host diseaseHalvard Bonig, Mareike Verbeek, Peter Herhaus, et al.
Blood Advances|January 6, 2023
CD19 CAR T cells are an effective therapy for posttransplant relapse in patients with B-lineage ALL: real-world data from GermanyPeter Bader, Claudia Rossig, Martin Hutter, et al.
Bone Marrow Transplantation|May 29, 2025
Harmonisation of quality control tests for academic production of CAR-T cells: a position paper from the WP-bioproduction of the UNITC consortiumChrystel Marton, Béatrice Clémenceau, Guillaume Dachy, et al.
Bone Marrow Transplantation|June 30, 2025
Correction: Harmonisation of quality control tests for academic production of CAR-T cells: a position paper from the WP-bioproduction of the UNITC consortiumChrystel Marton, Béatrice Clémenceau, Guillaume Dachy, et al.
Haematologica|November 23, 2019
Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)Ibrahim Yakoub-Agha, Christian Chabannon, Peter Bader, et al.
Blood|March 11, 2025
Clonal hematopoiesis landscape in frequent blood donorsDarja Karpova, Hector Huerga Encabo, Elisa Donato, et al.
Cell Stem Cell|May 8, 2026
Leukemic stem cell subtypes determine venetoclax resistance and therapeutic vulnerabilities in AMLAlexander Waclawiczek, Aino-Maija Leppä, Simon Renders, et al.
Bone Marrow Transplantation|January 31, 2018
Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM)Peter Bader, Zyrafete Kuçi, Shahrzad Bakhtiar, et al.
Pageof 15

Showing results (131-140 of 146) with videos related to

Sort By:
Pageof 15
Bone Marrow Transplantation|December 25, 2021
Results of a multicenter phase I/II trial of TCRαβ and CD19-depleted haploidentical hematopoietic stem cell transplantation for adult and pediatric patientsWolfgang A Bethge, Matthias Eyrich, Stephan Mielke, et al.
Journal of Translational Medicine|June 13, 2024
Correction: Real‑world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC‑FFM in ruxolitinib‑refractory acute graft‑versus‑host diseaseHalvard Bonig, Mareike Verbeek, Peter Herhaus, et al.
Journal of Translational Medicine|November 22, 2023
Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host diseaseHalvard Bonig, Mareike Verbeek, Peter Herhaus, et al.
Blood Advances|January 6, 2023
CD19 CAR T cells are an effective therapy for posttransplant relapse in patients with B-lineage ALL: real-world data from GermanyPeter Bader, Claudia Rossig, Martin Hutter, et al.
Bone Marrow Transplantation|May 29, 2025
Harmonisation of quality control tests for academic production of CAR-T cells: a position paper from the WP-bioproduction of the UNITC consortiumChrystel Marton, Béatrice Clémenceau, Guillaume Dachy, et al.
Bone Marrow Transplantation|June 30, 2025
Correction: Harmonisation of quality control tests for academic production of CAR-T cells: a position paper from the WP-bioproduction of the UNITC consortiumChrystel Marton, Béatrice Clémenceau, Guillaume Dachy, et al.
Haematologica|November 23, 2019
Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)Ibrahim Yakoub-Agha, Christian Chabannon, Peter Bader, et al.
Blood|March 11, 2025
Clonal hematopoiesis landscape in frequent blood donorsDarja Karpova, Hector Huerga Encabo, Elisa Donato, et al.
Cell Stem Cell|May 8, 2026
Leukemic stem cell subtypes determine venetoclax resistance and therapeutic vulnerabilities in AMLAlexander Waclawiczek, Aino-Maija Leppä, Simon Renders, et al.
Bone Marrow Transplantation|January 31, 2018
Effective treatment of steroid and therapy-refractory acute graft-versus-host disease with a novel mesenchymal stromal cell product (MSC-FFM)Peter Bader, Zyrafete Kuçi, Shahrzad Bakhtiar, et al.
Pageof 15